Código QR (código de barras bidimensional)

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

Background/AimsAdefovir (ADV) and lamivudine (LAM) combination therapy (ADV+LAM) has been a useful option for patients with LAM-resistant (LAM-r) chronic hepatitis B (CHB). However, the long-term outcomes of LAM+ADV and 1-mg entecavir (ETV) rescue therapies have still been limited. The aim of this s...

ver descrição completa

Na minha lista:
Principais autores: EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Association for the Study of the Liver 2014-09-01
coleção:Clinical and Molecular Hepatology
Assuntos:
Chronic hepatitis B
Lamivudine
Adefovir
Entecavir
Resistance
Acesso em linha:http://e-cmh.org/upload/pdf/cmh-20-267.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados